Development of A Deep Learning Approach for Analysing Scans of Rheumatoid Arthritis Patients using ⁹⁹ᵐTc-Maraciclatide Presented at the IEEE Nuclear Science Symposium and Medical Imaging Conference 2023 By Designer Development of A Deep Learning Approach for Analysing Scans of Rheumatoid Arthritis Patients using ⁹⁹ᵐTc-Maraciclatide Presented at the IEEE Nuclear Science Symposium and Medical Imaging Conference 2023 Read More »
The Development of a Deep Learning Model to Classify Inflammation from ⁹⁹ᵐTc-Maraciclatide Scans Presented at the BNMS Autumn Meeting 2023 By Designer The Development of a Deep Learning Model to Classify Inflammation from ⁹⁹ᵐTc-Maraciclatide Scans Presented at the BNMS Autumn Meeting 2023 Read More »
AI methods for automated identification of regions of inflammation from ⁹⁹ᵐTc-Maraciclatide imaging presented at the World Molecular Imaging Congress 2023 By Designer AI methods for automated identification of regions of inflammation from ⁹⁹ᵐTc-Maraciclatide imaging presented at the World Molecular Imaging Congress 2023 Read More »
Icahn School of Medicine at Mount Sinai commences clinical testing with Seracam® By Designer Icahn School of Medicine at Mount Sinai commences clinical testing with Seracam® Read More »
James Kaufman appointed as Chief Commercial Officer By Designer James Kaufman appointed as Chief Commercial Officer Read More »
First US site commences clinical testing of Seracam® By Designer First US site commences clinical testing of Seracam® Read More »
Initial Seracam® characterization results presented at BNMS Spring Meeting, Harrogate By Designer Initial Seracam® characterization results presented at BNMS Spring Meeting, Harrogate Read More »
First clinical testing of Seracam® commences at the University of Malaya By Designer First clinical testing of Seracam® commences at the University of Malaya Read More »
Seracam® to be presented at Parathyroid Symposium 2023: Oral presentation on qualitative and quantitative capabilities and novel features of Seracam® By Designer Seracam® to be presented at Parathyroid Symposium 2023: Oral presentation on qualitative and quantitative capabilities and novel features of Seracam® Read More »
Initial Seracam® characterization results presented at Cancer Diagnosis Network Theranostics Workshop By Designer Initial Seracam® characterization results presented at Cancer Diagnosis Network Theranostics Workshop Read More »
